A Perspective from JP Morgan Healthcare Conference 2012
Posted by: Patrick Terry on January 17, 2012 | 1 Comment »
Related to: Healthcare Trends, Uncategorized
The more things change, the more they seem the same.
Back in 2002 I can recall interesting development. Among the industry standard bearers who presented to the packed audience of bankers, investors and executives, a strange new group of presenter emerged: Hospitals, both large and small attempted to “sell” their wares to the highest bidders.
New Questions Emerge in Stratified (Personalized) Medicine
Posted by: Arshad Ahmed on January 9, 2012 | 3 Comments »
Related to: In Vitro Diagnostics, Therapeutics
There has been a lot of activity of late in the area of Stratified Medicine (SM)[1]. Almost every major Pharma and Biotech company has initiatives in this area. Recently, there have been high profile launches of innovative therapies such as Pfizer’s lung cancer drug called Xalkori and Roche’s Zelboraf for melanoma. In addition, there are approximately forty SM products in late stage registration trials that will enter the market in the near term. However, behind all this activity, there have been subtle changes in how some Pharma/Biotech companies are viewing SM and adapting to the changes resulting from it. The mindset within industry circles is quickly switching from “SM will shrink my market and is a threat to my business” to “SM is a strategic asset for us to gain competitive advantage.” The industry is moving from ad-hoc and decentralized approaches of SM to coordinated, centralized and process-driven approaches in planning and operational activities in SM across various geographies.
Posted by: Michael Tapella on January 6, 2012 | 3 Comments »
Related to: Healthcare Trends, Medical Devices
A panel comprised of Neil Schauer, PhD of Hospira, Joerg Windisch, PhD of Sandoz, Gillian Cannon, MBA, PhD of Merck, Earl Dye, PhD of Genentech, and Shin-Jae Chang, PhD of Celltrion revealed certain interesting takeaways.
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
